1.The Distribution of Intraocular Pressure and Its Association With Metabolic Syndrome in a Community.
Sang shin PARK ; Eun Hee LEE ; Ganchimeg JARGAL ; Domyung PAEK ; Sung Il CHO
Journal of Preventive Medicine and Public Health 2010;43(2):125-130
OBJECTIVES: The current study was performed to assess the distribution of intraocular pressure (IOP) and its association with metabolic syndrome (MS) in a community. METHODS: We measured IOP and MS components from 446 adults, age 20 or more years old, who reside in a community in Kyunggi Province, South Korea. We compared the level of IOP according to the number of metabolic abnormalities and between normal and abnormal metabolic components. Linear regression analyses were used to determine the relationship between IOP and metabolic components. RESULTS: No significant difference in IOP (mean +/- SE) was found between men (12.24 +/- 2.42) and women (12.55 +/- 2.41 mmHg, p > 0.1), while IOP of men tended to decrease as age increased (p for trend < 0.01). After adjusting for age, IOP of subjects with abdominal obesity in men and high blood pressure in women were significantly higher than those without abdominal obesity or high blood pressure (p < 0.05). Female subjects with MS showed significantly higher IOP than those without MS. Participants with more metabolic disturbances tended to have a greater IOP elevation with a linear trend after adjusting for age and sex. In the univariate regression analysis, age and waist circumference were significantly associated with IOP in men, but systolic and diastolic blood pressure were associated with IOP in women. In final multiple regression model, age, systolic blood pressure, and triglyceride were associated with IOP in women, and age in men. CONCLUSIONS: These findings suggest that MS and its components may be important determinants of elevated IOP.
Adult
;
Age Factors
;
Body Mass Index
;
Female
;
Health Behavior
;
Humans
;
Hypertension/physiopathology
;
Insulin Resistance/physiology
;
*Intraocular Pressure
;
Linear Models
;
Lipids/blood
;
Male
;
Metabolic Syndrome X/*complications/epidemiology/physiopathology
;
Middle Aged
;
Republic of Korea/epidemiology
;
Sex Factors
2.Comparison of the Metabolic Syndrome Risk Factor Prevalence Forty and Fifty Something Women.
Journal of Korean Academy of Nursing 2007;37(4):453-458
PURPOSE: The purpose of this study was to compare metabolic syndrome (MS) risk factor prevalence by obesity and age in middle-aged women. METHOD: Two hundred and fifty-one subjects were recruited from the health promotion center of a tertiary care hospital in an urban city. MS was defined by the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults(Adult Treatment Panel III)(ATPIII), and obesity was determined by body mass index(BMI)> or = 25kg/m2. RESULTS: The mean blood pressure, fasting glucose, total cholesterol, and triglyceride were significantly higher in the obese group than in the non-obese group. The prevalence of MS, hypertension, and impaired fasting glucose were significantly higher in the obese group than in the non-obese group. In the forties, blood pressure was significantly higher in the obese group than in the non-obese group. In the fifties, body fat, systolic blood pressure, fasting glucose, total cholesterol, and triglyceride were significantly higher in the obese group than in the non-obese group. CONCLUSIONS: These results show that the nurse should focus on the obese fifty year old female patients for improvement of the MS risk factors.
Women's Health
;
Adult
;
Blood Pressure
;
Body Fat Distribution
;
Body Mass Index
;
Cholesterol/blood
;
Female
;
Health Surveys
;
Humans
;
Metabolic Syndrome X/*epidemiology/etiology
;
Middle Aged
;
Models, Nursing
;
Obesity/*complications/epidemiology/physiopathology
;
Prevalence
;
Risk Factors
3.Impact of the Metabolic Syndrome on the Clinical Outcome of Patients with Acute ST-Elevation Myocardial Infarction.
Min Goo LEE ; Myung Ho JEONG ; Youngkeun AHN ; Shung Chull CHAE ; Seung Ho HUR ; Taek Jong HONG ; Young Jo KIM ; In Whan SEONG ; Jei Keon CHAE ; Jay Young RHEW ; In Ho CHAE ; Myeong Chan CHO ; Jang Ho BAE ; Seung Woon RHA ; Chong Jin KIM ; Donghoon CHOI ; Yang Soo JANG ; Junghan YOON ; Wook Sung CHUNG ; Jeong Gwan CHO ; Ki Bae SEUNG ; Seung Jung PARK
Journal of Korean Medical Science 2010;25(10):1456-1461
We sought to determine the prevalence of metabolic syndrome (MS) in patients with acute myocardial infarction and its effect on clinical outcomes. Employing data from the Korea Acute Myocardial Infarction Registry, a total of 1,990 patients suffered from acute ST-elevation myocardial infarction (STEMI) between November 2005 and December 2006 were categorized according to the National Cholesterol Education Program-Adult Treatment Panel III criteria of MS. Primary study outcomes included major adverse cardiac events (MACE) during one-year follow-up. Patients were grouped based on existence of MS: group I: MS (n=1,182, 777 men, 62.8+/-12.3 yr); group II: Non-MS (n=808, 675 men, 64.2+/-13.1 yr). Group I showed lower left ventricular ejection fraction (LVEF) (P=0.005). There were no differences between two groups in the coronary angiographic findings except for multivessel involvement (P=0.01). The incidence of in-hospital death was higher in group I than in group II (P=0.047), but the rates of composite MACE during one-year clinical follow-up showed no significant differences. Multivariate analysis showed that low LVEF, old age, MS, low high density lipoprotein cholesterol and multivessel involvement were associated with high in-hospital death rate. In conclusion, MS is an important predictor for in-hospital death in patients with STEMI.
Acute Disease
;
Age Factors
;
Aged
;
C-Reactive Protein/analysis
;
Cholesterol, LDL/blood
;
Coronary Angiography
;
Female
;
Humans
;
Male
;
Metabolic Syndrome X/*complications/epidemiology
;
Middle Aged
;
Multivariate Analysis
;
Myocardial Infarction/*complications/mortality/therapy
;
Predictive Value of Tests
;
Prognosis
;
Treatment Outcome
;
Ventricular Dysfunction, Left/complications/physiopathology